Michael R. Robinson
About
In The Last Decade
Michael R. Robinson
106 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Immunology 2.4k
- Oncology 2.4k
- Ophthalmology 2.3k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Molecular Biology 1.2k
Countries citing papers authored by Michael R. Robinson
This map shows the geographic impact of Michael R. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Robinson more than expected).
Fields of papers citing papers by Michael R. Robinson
This network shows the impact of papers produced by Michael R. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Robinson. The network helps show where Michael R. Robinson may publish in the future.
Co-authorship network of co-authors of Michael R. Robinson
This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Robinson. A scholar is included among the top collaborators of Michael R. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Robinson. Michael R. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 18 | |
| 5 | Corneal endothelial cell loss associated with selective laser trabeculoplasty | 1 |
| 6 | 34 | |
| 7 | Comparative Ocular Distribution of 14C-Latanoprost Following a Single Intracameral or Repeated Topical Ocular Dose in Dogs | 1 |
| 8 | The effect of elevated intraocular pressure on convective flow in the vitreous | 1 |
| 9 | BOVINE VITREOUS DIFFUSION COEFFICIENT MEASUREMENT AND COMPARISON OF PROHANCE WITH Gd-DTPA | 1 |
| 10 | Hindered convective transport of nanoparticles and macromolecules in the vitreous humor | 1 |
| 11 | 2 | |
| 12 | A Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine (CsA) Implant for Ocular Graft-vs.-Host Disease (GVHD) | 1 |
| 13 | 42 | |
| 14 | 33 | |
| 15 | Differences in the Intravitreal Dosage of Triamcinolone Acetonide Can Elicit Inhibition or Paradoxical Augmentation of Choroidal Neovascularization (CNV) in Rat | 1 |
| 16 | 51 | |
| 17 | Anterior Subtenon's Triamcinolone Acetonide (ASTTA) Injection for the Treatment of Diabetic Macular Edema: Animal and Clinical Findings | 2 |
| 18 | Anterior Subtenon’s Triamcinolone Acetonide (ASTA) Injection for the Treatment of Diabetic Macular Edema: 4 to 6 Month Clinical Followup | 2 |
| 19 | 18 | |
| 20 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.